TRIPLACE Registry: Conduction Disorders Following Transcatheter Tricuspid Valve Replacement

Tricuspid regurgitation (TR) has become increasingly common and has been associated to hospitalization for cardiac failure and increased mortality. 

The current guidelines continue to recommend surgical replacement, despite its 8 to 12% mortality, according to different series. 

Transcatheter tricuspid valve replacement (TTVR) is being looked at and different randomized trials have shown promising results. However, several questions remain unanswered, among them, post procedural conduction disorders. 

This analysis of the TRIPLACE registry (Global Multicenter Registry on Transcatheter Tricuspid Valve Replacement), included 185 inoperable severe TR patients with no prior definite pacemaker treated with TTVR.

The primary outcome was high grade atrioventricular (AV) block at 30 days. 

Mean patient age was 76, and they were mostly women. Mean TRISCORE was 14. Close to 90% were in functional class II-III, and over 40% had been hospitalized within12 months prior procedure. Also, 68% had hypertension, 27% diabetes, 49% kidney function deterioration, 14% COPD, 11% peripheral vascular disease, 77% peripheral edema, 24% ascites, 5% a history of TAVR, 5% CABG and 5% tricuspid surgery. 

Read also: Conduction Disorders in TAVR: Is Colchicine Useful?

The most frequent TR etiology was secondary (84%), followed by primary and in lower proportion mixed. Most predominant TR degree was torrential (44%), followed by severe (33%) and massive in the remaining cases.

At baseline EKG, 88% presented atrial fibrillation, 6% first degree AV block, 23% complete right bundle branch block (RBBB), 10% incomplete RBBB, 3% complete left BBB, 7% anterior or posterior fascicular block, and 2.7% bifascicular block.

As regards devices, the EVOQUE was used in 75 patients, the LUX PLUS in 53, CARDIOVALVE in 29 and others in 28.

Read also: Abbreviated Dual Antiplatelet Therapy with Prasugrel: 4D-ACS.

The primary outcome was seen in 13.5% (25 patients). Most high grade AV blocks were seen during the first week after procedure (88%). The need for pacemaker implantation was 11.9% (45% leadless, 27.3% coronary sinus leads, and the rest with other techniques. Malapposition was observed in 5 patients, and there was no embolization, migration or mortality. 

Complete or fascicular LBBB (anterior or posterior) at baseline was associated with higher risk of high grade AV block. 

Conclusion

High grade AV block was observed in 13.5% of patients undergoing transcatheter tricuspid valve replacement, mostly during the first week after procedure. The presence of complete / fascicular LBBB at baseline was significantly associated to high grade AV block after TTVR. 

Original Title: Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement. The TRIPLACE Registry.

Reference: Andrea Scotti,et al. JACC Cardiovasc Interv. 2025;18:1789–1799.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...